Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials

Arterial and venous thrombotic events in COVID-19 cause significant morbidity and mortality among patients. Although international guidelines agree on the need for anticoagulation, it is unclear whether full-dose heparin anticoagulation confers additional benefits over prophylactic-dose anticoagulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilia, Eros, Belletti, Alessandro, Fresilli, Stefano, Finco, Gabriele, Landoni, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362611/
https://www.ncbi.nlm.nih.gov/pubmed/35922578
http://dx.doi.org/10.1007/s11239-022-02681-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362611/
https://www.ncbi.nlm.nih.gov/pubmed/35922578
http://dx.doi.org/10.1007/s11239-022-02681-x

Ejemplares similares